MMPI-1154 |
Catalog No.GC39745 |
Le MMPI-1154 est un nouvel inhibiteur MMP-2 cardio-cytoprotecteur prometteur de l'acide imidazole-carboxylique (ICA) (IC50 = 6,6 μM) et peut être utilisé pour l'étude de l'infarctus aigu du myocarde.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1382722-47-5
Sample solution is provided at 25 µL, 10mM.
MMPI-1154 is a promising novel cardio-cytoprotective imidazole-carboxylic acid (ICA) MMP-2 inhibitor(IC50=6.6 μM) and can be used for the study of acute myocardial infarction. MMPI-1154 also inhibits the activity of MMP-13, MMP-1 and MMP-9 with IC50s of 1.8 μM,10 μM, and 13 μM, respectively[1].
[1]. PÉter Bencsik, et al. Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection.Front Pharmacol. 2018 Apr 5;9:296.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *